RE: mindanao5 Nov 2018 12:56
O/t:
"Hi Triggerblade, I see Chartist conveniently not answered your 22 Sep post on his dodgy N4P share he was heralding not long before it dropped through the floor." mindanao
(1 Oct 2018)
Not sure what you two are on about: N4P pharma has been a strong buy as from 5.50p, last year autumn, just like ARS.
- Both shares attracted the interest of a number of posters who held both.
- Both were ramped into the sky, while N4P raced to 35p(!) in March/April, where it peaked out. While Asiamet peaked in April.
- Both shares saw weeklong arguments, while N4P was signaled as a sell, as from 33, 29 and 25p ahead.
- Both shares crashed to 5ish recently.
- Both shares received a buy alert recently.
N4P triggered a new long term buy signal just a few weeks ago, from 4.90p ahead. Now it looks like both shares are in their racing pits for a fresh new start:
ARS 6.25p
N4P 6.95p